LAUREN SLAKEY POINTER
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEW ORLEANS, LA NPI 1609255231
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology LA ABBVIE INC. All categories
General Payments — all program years on this page
$3,371.97
- Category: General Payments
- Program years: PY2018–2024
- Record count: 144
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,339.44 across 73 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,339.44 | 73 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $575.26 | 37 |
| Janssen Biotech, Inc. | $145.47 | 8 |
| PFIZER INC. | $121.58 | 6 |
| GENZYME CORPORATION | $90.06 | 4 |
| Phathom Pharmaceuticals, Inc. | $71.34 | 3 |
| Ardelyx, Inc. | $45.42 | 2 |
| Celgene Corporation | $44.21 | 2 |
| Fresenius Kabi USA, LLC | $39.67 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.87 | 1 |
| Celltrion USA Inc. | $30.76 | 1 |
| EVOKE PHARMA, INC. | $24.15 | 1 |
| Madrigal Pharmaceuticals | $24.00 | 1 |
| Teva Pharmaceuticals USA, Inc. | $23.09 | 1 |
| Braintree Laboratories, Inc. | $20.72 | 1 |
| Biocon Biologics Inc | $18.47 | 1 |
| Gilead Sciences, Inc. | $18.29 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.08 | 1 |
By program year
Records — PY2024 (73)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.